Title:
HETEROCYCLIC SUBSTITUTED QUINAZOLINE, PREPARATION METHOD THEREFOR, AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/067744
Kind Code:
A1
Abstract:
The present invention relates to heterocyclic substituted quinazoline, a preparation method therefor, and use thereof. Specifically, the compound of the present invention has a structure represented by formula (IA), formula (IB) or formula (IC), and the compound has a very good selective regulation effect on SOS1 hydrolysis.
More Like This:
| JP6386299 | Organic compounds for light emitting devices |
| WO/1994/014787 | NOVEL SIDECHAIN-BEARING TAXANES AND INTERMEDIATES THEREOF |
| WO/2021/124155 | BENZIMIDAZOLE DERIVATIVES |
Inventors:
LV BINHUA (CN)
CUI DAWEI (CN)
PANG XUDONG (CN)
CUI DAWEI (CN)
PANG XUDONG (CN)
Application Number:
PCT/CN2023/122243
Publication Date:
April 04, 2024
Filing Date:
September 27, 2023
Export Citation:
Assignee:
SUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD (CN)
SHANGHAI ZELGEN PHARMA TECH CO LTD (CN)
SHANGHAI ZELGEN PHARMA TECH CO LTD (CN)
International Classes:
C07D405/14; A61K31/496; A61K31/506; A61K31/5377; A61P35/00; C07D401/14; C07D413/14
Domestic Patent References:
| WO2022061348A1 | 2022-03-24 | |||
| WO2022188819A1 | 2022-09-15 | |||
| WO2022197862A1 | 2022-09-22 | |||
| WO2022266248A1 | 2022-12-22 |
Foreign References:
| CN115043817A | 2022-09-13 | |||
| US20230293702A1 | 2023-09-21 |
Attorney, Agent or Firm:
XU & PARTNERS, LLC. (CN)
Download PDF: